asa guidelines for glp-1 drugs 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists 🔸 Should GLP-1 RAs be

6

Identifying these mutations enables the clinician to target patients to prescribe antioxidant protection regimes or chemotherapy regimens that will overcome these genetic defects [17]

This is seen in patients with rheumatoid arthritis, or in those with inflammatory skin conditions such as acne or psoriasis, where LPS can drive inflammation and damage

[4] Patients are counseled to cleanse with a mild, non-foaming wash, pat dry, wait ten minutes, then apply a pea-sized amount over the entire face at bedtime

The peptide's favorable safety profile in animal studies and its stability across various administration routes have contributed to its growing popularity